肝硬化对3.0 T MRI扩散加权成像中肝细胞癌、瘤周亚区及背景肝特征的影响:对手术规划的临床意义
这项回顾性研究纳入198例病理证实的肝细胞癌患者(102例伴肝硬化、96例无肝硬化),比较DWI生成的ADC与eADC图在肝细胞癌、近端瘤周(<1.0 cm)、远端瘤周(1.0-1.5 cm)、远隔肝(1.5-3.0 cm)及背景肝(>3.0 cm)的数值差异,并评估诊断效能。结果显示肝硬化不影响肝细胞癌的DWI特征,但削弱了瘤周扩散梯度;低b值可能增强无肝硬化肝脏的瘤周对比,对手术切缘评估有潜在意义。
要点
- 肝硬化不改变肝细胞癌本身的DWI特征,但削弱了瘤周ADC梯度。
- 无肝硬化肝脏在低b值下可见距离依赖的ADC梯度,肝硬化肝脏中该梯度消失。
- 鉴别肝细胞癌与非肿瘤组织时,肝硬化组b=600 s/mm²的ADC最优(AUC=0.758),无肝硬化组b=100 s/mm²最优(AUC=0.755)。
核心结论
- 肝硬化不影响肝细胞癌的DWI特征,但削弱了瘤周扩散梯度;低b值可能增强无肝硬化肝脏的瘤周对比,对手术切缘评估有潜在意义。
研究设计与样本
- 回顾性研究纳入198例病理证实的肝细胞癌患者,其中伴肝硬化102例、无肝硬化96例,在3.0 T MRI上采用b=50、100、600 s/mm²的DWI以单指数模型生成ADC与eADC图。
关键影像表现/征象
- 两组中肝细胞癌的ADC均显著低于其他所有组织(均P < 0.001)。
- 无肝硬化肝脏在低b值下可见距离依赖的ADC梯度,肝硬化肝脏中该梯度消失。
诊断标准与关键数值
- 鉴别肝细胞癌与非肿瘤组织:肝硬化组b=600 s/mm²的ADC最优,AUC=0.758;无肝硬化组b=100 s/mm²最优,AUC=0.755。
- 鉴别近端瘤周组织与远隔肝:无肝硬化组b=50 s/mm²的ADC获得最高AUC(0.792)。
- 观察者间一致性:ICC ADC=0.757,eADC=0.847。
临床应用与阅片要点
- 阅片时注意肝硬化背景可能掩盖瘤周扩散梯度,影响对瘤周浸润范围的判断。
- 无肝硬化患者可借助低b值ADC增强瘤周对比,辅助评估手术切缘。
- 鉴别肝细胞癌与非肿瘤组织时,肝硬化患者宜参考b=600 s/mm²的ADC,无肝硬化患者宜参考b=100 s/mm²的ADC。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the effect of liver cirrhosis on diffusion-weighted imaging (DWI) features of hepatocellular carcinoma (HCC) and its peri-tumoral microenvironment at 3.0 T magnetic resonance imaging (MRI).
METHODS: This retrospective study included 198 patients with pathologically confirmed HCC (102 with cirrhosis, 96 without). Apparent diffusion coefficient (ADC) and exponential ADC (eADC) maps were generated from DWI (b = 50,100,600 s/mm2) using a mono-exponential model. ADC and eADC values were compared between groups across five tissue types: HCC, proximal peri-tumoral (<1.0 cm), distal peri-tumoral (1.0-1.5 cm), distant liver (1.5-3.0 cm), and background liver (>3.0 cm). Diagnostic performance was assessed using ROC analysis.
RESULTS: Inter-observer agreement was excellent (ICC: ADC = 0.757, eADC = 0.847). In both groups, HCC showed significantly lower ADC than all other tissues (all P < 0.001). In non-cirrhotic livers, a distance-dependent ADC gradient was observed at low b-values, which was absent in cirrhotic livers. For distinguishing HCC from non-tumorous tissues, ADC at b = 600 s/mm2 performed best in cirrhotic livers (AUC = 0.758), while ADC at b = 100 s/mm2 was optimal in non-cirrhotic livers (AUC = 0.755). For differentiating proximal peri-tumoral tissue from distant liver, ADC at b = 50 s/mm2 achieved the highest AUC in non-cirrhotic patients (0.792).
CONCLUSION: Cirrhosis does not affect HCC DWI characteristics but blunts peri-tumoral diffusion gradients. Lower b-values may enhance peri-tumoral contrast in non-cirrhotic livers, with potential implications for surgical margin assessment.
引用
- Zhu J, Du Y, Hu Y, et al. Effects of cirrhosis on 3.0 T MRI DWI features of hepatocellular carcinoma, peri-tumoral sub-zones, and background liver: clinical implications for surgical planning. Eur J Radiol. 2026. PMID: 41833232. doi:10.1016/j.ejrad.2026.112791
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。